The latest Bench to Bedside column reviews new guidance on the treatment of drug-susceptible and drug-resistance Mycobacterium tuberculosis infections.
Megan E. Klatt, PharmD, BCIDP, DPLA
Advertisement
Megan E. Klatt, PharmD, BCIDP, DPLA, is an infectious diseases/ antimicrobial stewardship clinical pharmacist at The University of Kansas Health System in Kansas City, KS.
Articles by Megan E. Klatt, PharmD, BCIDP, DPLA
Shorter durations of antibiotic therapy demonstrate similar efficacy and may improve safety compared with longer courses for certain infections.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
One Health System's Evolution in the Rise in Dalbavancin Prescribing for Off-Label Indications
2
Single-Tablet HIV Combination Therapy Demonstrates Noninferiority When Switched From Multitablet Regimens
3
First Confirmed Death From Meat Allergy Spread by Lone Star Ticks
4
US Hospital Safety Rankings Unveiled
5
